OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Efficacies of FLT3 Inhibitors in Patients with Acute Myeloid Leukemia
Gyung Hyuck Ko, Byeong-Bae Park, Jieun Uhm
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12708-12708
Open Access | Times Cited: 11
Gyung Hyuck Ko, Byeong-Bae Park, Jieun Uhm
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12708-12708
Open Access | Times Cited: 11
Showing 11 citing articles:
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy
Liang Shen, Bo Wang, ShaoPeng Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 922-951
Closed Access | Times Cited: 16
Liang Shen, Bo Wang, ShaoPeng Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 922-951
Closed Access | Times Cited: 16
A Review of FLT3 Kinase Inhibitors in AML
Cristina Negotei, Andrei Coliţă, Iuliana Mitu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 20, pp. 6429-6429
Open Access | Times Cited: 22
Cristina Negotei, Andrei Coliţă, Iuliana Mitu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 20, pp. 6429-6429
Open Access | Times Cited: 22
A systematic review of second-generation FLT3 inhibitors for treatment of patients with relapsed/refractory acute myeloid leukemia
Alireza Mohebbi, Fahimeh Shahriyary, Vida Farrokhi, et al.
Leukemia Research (2024) Vol. 141, pp. 107505-107505
Closed Access | Times Cited: 5
Alireza Mohebbi, Fahimeh Shahriyary, Vida Farrokhi, et al.
Leukemia Research (2024) Vol. 141, pp. 107505-107505
Closed Access | Times Cited: 5
Targeting FLT3 for treating diseases: FLT3 inhibitors
Qingfeng Rong, Yu Lu, Wen Zhang, et al.
Drug Discovery Today (2025), pp. 104367-104367
Closed Access
Qingfeng Rong, Yu Lu, Wen Zhang, et al.
Drug Discovery Today (2025), pp. 104367-104367
Closed Access
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies
Gabriele Carullo, Sara Rossi, Valentina Giudice, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2125-2142
Closed Access | Times Cited: 2
Gabriele Carullo, Sara Rossi, Valentina Giudice, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2125-2142
Closed Access | Times Cited: 2
The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients
Xiaoning Wang, Jie Wang, Suhua Wei, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Xiaoning Wang, Jie Wang, Suhua Wei, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Understanding the Role of Activation Loop Mutants in Drug Efficacy for FLT3-ITD
Julhash U. Kazi, Lina Al Ashiri, Rituraj Purohit, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5426-5426
Open Access | Times Cited: 4
Julhash U. Kazi, Lina Al Ashiri, Rituraj Purohit, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5426-5426
Open Access | Times Cited: 4
The safety and efficacy of the re-administration of gilteritinib in a patient with FLT3-mutated R/R AML with CNS relapse: a case report
Yue-Ru Ji, Zhuo Wan, Jian Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Yue-Ru Ji, Zhuo Wan, Jian Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
UPLC-MS/MS method development and application to pharmacokinetic study in rats and dogs of Flonoltinib Maleat
Ziyan Ma, Minghai Tang, Qianlun Pu, et al.
Journal of Chromatography B (2023) Vol. 1223, pp. 123696-123696
Closed Access | Times Cited: 3
Ziyan Ma, Minghai Tang, Qianlun Pu, et al.
Journal of Chromatography B (2023) Vol. 1223, pp. 123696-123696
Closed Access | Times Cited: 3
Construction and validation of a prognostic model for overall survival time of patients with ovarian cancer by metabolism‐related genes
Deshui Kong, Hongyan Guo
Journal of Obstetrics and Gynaecology Research (2024)
Open Access
Deshui Kong, Hongyan Guo
Journal of Obstetrics and Gynaecology Research (2024)
Open Access
Human Leukocyte Antigen-DR and Cluster Designation 34: Double-negative Acute Myeloid Leukemias – Our Experience in Clinical Setting
Preeti Tripathi, Sanjeev Khera, Rajiv Kumar, et al.
Journal of Marine Medical Society (2024)
Open Access
Preeti Tripathi, Sanjeev Khera, Rajiv Kumar, et al.
Journal of Marine Medical Society (2024)
Open Access
Targeting AML Growth: Vitamins' Influence on FLT3, NPM1, and RUNX1 Interactions
Tunnisha Dasgupta, Rounak Chatterjee, Moumita Mondal, et al.
Research Square (Research Square) (2023)
Open Access
Tunnisha Dasgupta, Rounak Chatterjee, Moumita Mondal, et al.
Research Square (Research Square) (2023)
Open Access
